Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInforma Regulatory News (INF)

Share Price Information for Informa (INF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 847.80
Bid: 849.60
Ask: 850.00
Change: 6.80 (0.81%)
Spread: 0.40 (0.047%)
Open: 841.60
High: 852.80
Low: 841.00
Prev. Close: 841.00
INF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

24 Jan 2024 07:00

RNS Number : 6769A
Informa PLC
24 January 2024
 

Informa PLC Press Release

24 January 2024

Informa Share Buyback Programme

Update on GAP 2 shareholder returns

Informa PLC ('the Company') (LSE: INF.L), the international B2B Events, Specialist Data, Digital Services and Academic Markets Group today provided an update on its Share Buyback programme that forms part of the 2021-2024 Growth Acceleration Plan 2 ('GAP 2').

Share Buyback Programme

GAP 2 is Informa's four-year programme to create a more focused, higher growth business. This includes accelerated investment in its two businesses with scale leadership positions, B2B Markets and Academic Markets, and the divestment of its Informa Intelligence portfolio of businesses.

GAP 2 also includes a commitment to accelerate shareholder returns, sharing some of the divestment proceeds with shareholders, alongside increased investment into the Group's two leadership businesses. This led to the resumption of ordinary dividends and the launch of a Share Buyback Programme.

On 14 November 2023, this buyback programme was extended by £150m to £1.15bn.

As part of the extended Share Buyback, on 23 January 2024, the Company purchased 265,395 ordinary shares for cancellation through Morgan Stanley & Co. International plc at an average price of 753.59 pence per share. The highest and lowest purchase price paid per share were 757.40 and 749.20 respectively, with the aggregate details of shares purchased by trading venue as outlined in the table below:

Trading venue

Weighted average price paid per share (GBp)

Aggregate number of shares purchased

Lowest price paid per share(GBp)

Highest price paid per share(GBp)

London Stock Exchange

753.70

102,013

749.20

757.40

Chi-X (CXE)

753.62

123,153

749.20

757.40

BATS (BXE)

753.22

26,706

749.20

755.20

AQUIS (AQXE)

753.29

13,523

749.20

755.20

Following settlement of the above purchases and cancellation of the purchased ordinary shares, the Company's total number of ordinary shares in issue, and its total voting rights, will be 1,372,675,684 ordinary shares. The Company does not hold any shares in Treasury.

In accordance with Article 5(1)(b) of the Market Abuse Regulation, a full breakdown of the individual trades made as part of the buyback programme is detailed in the attachment.

http://www.rns-pdf.londonstockexchange.com/rns/6769A_1-2024-1-23.pdf

Enquiries

Richard Menzies-Gow, Director of IR & Communications

+44 (0) 20 8052 2787

Heledd Hanscomb, Deputy Company Secretary

+44 (0) 20 8052 0661

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBIGDBSGDDGSX
Date   Source Headline
17th Mar 20227:00 amRNSTransaction in Own Shares
16th Mar 20227:00 amRNSInforma Share Buyback Programme
15th Mar 20225:53 pmRNSHolding(s) in Company
15th Mar 20225:35 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNS2021 Full Year Results Statement
15th Mar 20227:00 amRNSHolding(s) in Company
8th Mar 20227:00 amRNSInforma Share Buyback Programme
7th Mar 20227:00 amRNSInforma Share Buyback Programme
4th Mar 20227:00 amRNSInforma Share Buyback Programme
3rd Mar 20227:00 amRNSInforma Share Buyback Programme
2nd Mar 20227:00 amRNSInforma Share Buyback Programme
2nd Mar 20227:00 amRNSTotal Voting Rights
1st Mar 20227:00 amRNSInforma Share Buyback Programme
28th Feb 20227:00 amRNSInforma Share Buyback Programme
25th Feb 20227:00 amRNSTransaction in Own Shares
24th Feb 20227:00 amRNSInforma Share Buyback Programme
23rd Feb 20227:00 amRNSInforma Share Buyback Programme
22nd Feb 20227:00 amRNSInforma Share Buyback Programme
21st Feb 20225:34 pmRNSHolding(s) in Company
21st Feb 20225:29 pmRNSHolding(s) in Company
21st Feb 20227:55 amRNSInforma Share Buyback Programme
18th Feb 20227:00 amRNSInforma Share Buyback Programme
17th Feb 20227:00 amRNSInforma Share Buyback Programme
16th Feb 202211:18 amRNSHolding(s) in Company
16th Feb 20227:00 amRNSInforma Share Buyback Programme
15th Feb 20227:00 amRNSInforma Share Buyback Programme
10th Feb 20228:10 amRNSDivestment of Pharma Intelligence for £1.9bn
4th Feb 20226:03 pmRNSBlock listing Interim Review
4th Feb 20224:03 pmRNSNotice of Results
1st Feb 20224:17 pmRNSHolding(s) in Company
20th Jan 20224:58 pmRNSHolding(s) in Company
13th Jan 20225:40 pmRNSBoard Update
13th Jan 20227:00 amRNSHolding(s) in Company
12th Jan 20225:56 pmRNSHolding(s) in Company
12th Jan 20225:52 pmRNSHolding(s) in Company
12th Jan 20225:51 pmRNSHolding(s) in Company
17th Dec 20212:16 pmRNSDirector/PDMR Shareholding
14th Dec 202110:53 amRNSHolding(s) in Company
14th Dec 202110:19 amRNSDirector/PDMR Shareholding
7th Dec 202112:00 pmRNSCapital Markets Day - Growth Acceleration Plan II
26th Nov 20213:32 pmRNSHolding(s) in Company
26th Nov 20213:27 pmRNSHolding(s) in Company
17th Nov 20217:00 amRNSTrading Statement & Board Update
1st Oct 20217:00 amRNSBoard Update
5th Aug 20216:19 pmRNSBlock listing Interim Review
5th Aug 20216:07 pmRNSDirector/PDMR Shareholding
29th Jul 20217:00 amRNS2021 Half Year Results Statement
3rd Jun 20215:16 pmRNSResult of AGM
3rd Jun 20217:00 amRNSTrading Update
2nd Jun 20214:42 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.